Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (175)	5/10/1999 9:14:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 555

OTOH, I view a rights offering as a much better alternative than a death-spiral convertible. In the UK rights offerings are common, and maybe they might spread to the US. A rights offering at least gives the ordinary shareholders the choice whether to put up more cash or get diluted. For example, a company like ARIA might well have gotten away with a rights offering instead of the deadly package they actually went with. Peter